Medical Properties Trust, Inc. (NYSE:MPW) Shares Bought by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd increased its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 506.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,207 shares of the real estate investment trust’s stock after acquiring an additional 52,790 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Medical Properties Trust were worth $250,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Silver Point Capital L.P. raised its holdings in shares of Medical Properties Trust by 155.3% in the 3rd quarter. Silver Point Capital L.P. now owns 6,000,000 shares of the real estate investment trust’s stock worth $35,100,000 after purchasing an additional 3,650,000 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Medical Properties Trust by 353.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock valued at $20,625,000 after buying an additional 2,748,245 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Medical Properties Trust by 435.5% in the fourth quarter. SG Americas Securities LLC now owns 923,756 shares of the real estate investment trust’s stock valued at $3,649,000 after buying an additional 751,256 shares in the last quarter. Wilsey Asset Management Inc. lifted its position in shares of Medical Properties Trust by 8.5% during the 4th quarter. Wilsey Asset Management Inc. now owns 4,652,803 shares of the real estate investment trust’s stock valued at $18,379,000 after acquiring an additional 362,582 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Medical Properties Trust by 21.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,704,785 shares of the real estate investment trust’s stock worth $9,973,000 after acquiring an additional 303,628 shares in the last quarter. 71.79% of the stock is owned by institutional investors and hedge funds.

Medical Properties Trust Price Performance

Shares of MPW opened at $5.64 on Wednesday. The business’s 50-day moving average is $4.48 and its 200-day moving average is $4.67. The company has a debt-to-equity ratio of 1.69, a current ratio of 2.38 and a quick ratio of 2.38. The company has a market capitalization of $3.38 billion, a price-to-earnings ratio of -1.34, a P/E/G ratio of 1.01 and a beta of 1.32. Medical Properties Trust, Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $6.55.

Medical Properties Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 10th will be given a $0.08 dividend. The ex-dividend date is Monday, March 10th. This represents a $0.32 dividend on an annualized basis and a yield of 5.68%. Medical Properties Trust’s payout ratio is -8.42%.

Insider Buying and Selling at Medical Properties Trust

In other news, CAO James Kevin Hanna sold 11,641 shares of the company’s stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $3.72, for a total value of $43,304.52. Following the transaction, the chief accounting officer now directly owns 366,913 shares of the company’s stock, valued at approximately $1,364,916.36. This represents a 3.08 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.53% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Truist Financial cut their target price on Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating on the stock in a research report on Thursday, December 19th. Mizuho cut their price objective on Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Thursday, December 5th. Finally, StockNews.com upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Monday. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $4.92.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.